Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 506598, 7 pages
http://dx.doi.org/10.1155/2015/506598
Research Article

Species Identification and Clarithromycin Susceptibility Testing of 278 Clinical Nontuberculosis Mycobacteria Isolates

1Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University, Tongzhou District, Beijing 101149, China
2Reference Lab, Beijing Chest Hospital, Capital Medical University, Tongzhou District, Beijing 101149, China
3Department of Pharmacology, Beijing Chest Hospital, Capital Medical University, Tongzhou District, Beijing 101149, China

Received 22 July 2014; Accepted 20 December 2014

Academic Editor: Parissa Farnia

Copyright © 2015 Wenjuan Nie et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. T. Henry, L. Inamdar, D. O'Riordain, M. Schweiger, and J. P. Watson, “Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response,” European Respiratory Journal, vol. 23, no. 5, pp. 741–746, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. D. E. Griffith, T. Aksamit, B. A. Brown-Elliott et al., “An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases,” The American Journal of Respiratory and Critical Care Medicine, vol. 175, no. 4, pp. 367–416, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. Clinical and Laboratory Standards Institute, “Susceptibility testing of mycobacteria, norcardiae, and other aerobic actinomycetes; approved standard,” CLSI Document M24-A, CLSI, Wayne, Pa, USA, 2003. View at Google Scholar
  4. K. A. Nash, A. B. Brown-Elliott, and R. J. Wallace Jr., “A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 4, pp. 1367–1376, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. H.-Y. Kim, Y. Kook, Y.-J. Yun et al., “Proportions of Mycobacterium massiliense and Mycobacterium bolletii strains among Korean Mycobacterium chelonae-Mycobacterium abscessus group isolates,” Journal of Clinical Microbiology, vol. 46, no. 10, pp. 3384–3390, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Nie, H. Duan, H. Huang et al., “Species identification using rpoB and hsp65 and susceptibility testing to eight antibiotics of Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii,” International Journal of Infectious Diseases, vol. 25, no. 8, pp. 170–174, 2014. View at Google Scholar
  7. I. Ahmed, K. Jabeen, and R. Hasan, “Identification of non-tuberculous mycobacteria isolated from clinical specimens at a tertiary care hospital: a cross-sectional study,” BMC Infectious Diseases, vol. 13, article 493, 2013. View at Publisher · View at Google Scholar
  8. W.-J. Koh, O. J. Kwon, K. Jeon et al., “Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea,” Chest, vol. 129, no. 2, pp. 341–348, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. A. M. Zelazny, J. M. Root, Y. R. Shea et al., “Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii,” Journal of Clinical Microbiology, vol. 47, no. 7, pp. 1985–1995, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. J. van Ingen, R. de Zwaan, R. P. N. Dekhuijzen, M. J. Boeree, and D. van Soolingen, “Clinical relevance of Mycobacterium chelonae-abscessus group isolation in 95 patients,” Journal of Infection, vol. 59, no. 5, pp. 324–331, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. A.-L. Roux, E. Catherinot, F. Ripoll et al., “Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in France,” Journal of Clinical Microbiology, vol. 47, no. 12, pp. 4124–4128, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Harada, Y. Akiyama, A. Kurashima et al., “Clinical and microbiological differences between M. abscessus and Mycobacterium massiliense lung diseases,” Journal of Clinical Microbiology, vol. 50, no. 11, pp. 3556–3561, 2012. View at Publisher · View at Google Scholar
  13. E. Macheras, A. L. Roux, S. Bastian et al., “Multilocus sequence analysis and rpoB sequencing of Mycobacterium abscessus strains,” Journal of Clinical Microbiology, vol. 49, no. 2, pp. 491–499, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Sassi, I. Ben Kahla, and M. Drancourt, “Mycobacterium abscessus multispacer sequence typing,” BMC Microbiology, vol. 13, article 3, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Adékambi and M. Drancourt, “Mycobacterium bolletii respiratory infections,” Emerging Infectious Diseases, vol. 15, no. 2, pp. 302–305, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. S. C. Leao, E. Tortoli, C. Viana-Niero et al., “Characterization of mycobacteria from a major Brazilian outbreak suggests that revision of the taxonomic status of members of the Mycobacterium chelonae-M. abscessus group is needed,” Journal of Clinical Microbiology, vol. 47, no. 9, pp. 2691–2698, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. W. J. Koh, K. Jeon, N. Y. Lee et al., “Clinical significance of differentiation of Mycobacterium massiliense from M. abscessus,” The American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 3, pp. 405–410, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. B. A. Brown, R. J. Wallace Jr., G. O. Onyi, V. de Rosas, and R. J. Wallace III, “Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms,” Antimicrobial Agents and Chemotherapy, vol. 36, no. 1, pp. 180–184, 1992. View at Google Scholar · View at Scopus